[Rinshō ketsueki] The Japanese journal of clinical hematology
The most recent articles from:
Rinsho Ketsueki
-
Multicenter Study Clinical Trial
[Autologous peripheral blood stem cell transplantation for Japanese multiple myeloma patients: results of a feasibility study].
A feasibility study on high-dose therapy with autologous peripheral blood stem cell transplantation (HDT/PBSCT) was performed in Japanese patients with multiple myeloma (MM). Twenty evaluable patients younger than 65 years old with stage II/III MM were enrolled in this study. Three courses of VAD were used as initial chemotherapy. ⋯ The median EFS duration was 18 months. These preliminary results indicated that HDT/PBSCT is feasible for Japanese MM patients. A prospective randomized clinical trial will be required to assess the efficacy.